Qinecsa 2025 Events Round-Up - Qinecsa

Qinecsa 2025 Events Round-Up

As the year comes to a close, Qinecsa reflects on a successful 2025 filled with global engagement and innovation in pharmacovigilance. Our team participated in key industry events across North America, Europe, Asia, and the Middle East, sharing insights, showcasing technology, and building meaningful partnerships. We began the year in Baltimore at the DIA Global Pharmacovigilance & Risk Management Strategies Conference, where we welcomed attendees to Booth #202 and demonstrated how our end-to-end PV solutions are transforming patient safety. In March, we joined DIA Europe in Basel, aligning with the event’s focus on sustainability, innovation, and collaboration, values that are central to our mission. May brought us to London for the Pharmacovigilance EU Congress, where we explored the evolving drug safety landscape and the growing role of automation and AI. Shortly after, we attended ISoP’s mid-year symposium in Sweden, continuing our commitment to global dialogue in PV. In June, we returned to Basel for the World Drug Safety Summit, engaging with leaders on how our technologies enhance compliance and efficiency. July took us to Boston for the Pharmacovigilance US Congress, a premier gathering that offered valuable opportunities to connect and collaborate on the future of patient safety. September was a busy month, with Veronika Valdova presenting on MDR case studies at the Medical Device Biocompatibility & Safety Summit, and our team attending the Global Drug Safety & PV Outsourcing Summit in Mumbai, represented by Santosh Nair and Dr. Preeti Verma. October saw our CEO Adam Sherlock and Account Director Luca Longo join global PV leaders at ISoP’s 24th Annual Meeting in Cairo. We also participated in the World Drug Safety Congress Europe in Amsterdam, continuing our conversations on innovation and collaboration. To close the year, we attended the World Drug Safety Congress Americas, where we joined a fireside chat on AI, trust, and transformation in PV. Our team also held a ‘Happy Hour’ reception where people could relax with a glass of wine and have fun in the photo booth. Thank you to everyone who joined us throughout 2025. We’re excited to continue our journey in 2026 and remain committed to advancing pharmacovigilance worldwide.

Recent News & Events

Qinecsa Releases HaloPV 6.2 to Strengthen Global Pharmacovigilance Compliance and Platform Stability

Qinecsa signals next growth chapter with appointment of Alex Livingstone-Learmonth as Chief Commercial Officer

Drug Safety Tech Trailblazer Joins Qinecsa

Get to know our Chief Operating Officer, John Cogan

Join Qinecsa at DIA Europe 2025

Join Qinecsa at DIA 2025 Pharmacovigilance & Risk Management Strategies Conference